AIM IMMUNOTECH INC. Finite-Lived Intangible Assets, Net
AIM IMMUNOTECH INC. (AIM) had Finite-Lived Intangible Assets, Net of $1.71 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2026-08-07
- 2026-06-30: Finite-Lived Intangible Assets, Net $1.71M.
- 2026-03-31: Finite-Lived Intangible Assets, Net $1.66M.
- 2025-12-31: Finite-Lived Intangible Assets, Net $1.66M.
- 2025-09-30: Finite-Lived Intangible Assets, Net $2.04M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2026-06-30 | $1.71M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.66M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.66M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $2.04M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | $2.17M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.27M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.59M 10-K · filed 2026-03-27 | |
| 2024-09-30 | $2.53M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.49M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $2.31M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.31M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.15M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.04M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.90M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.94M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.01M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.01M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $1.99M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.97M 10-Q · filed 2023-08-14 | |
| 2021-09-30 | $1.84M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.78M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $1.80M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.50M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $1.41M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.38M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.24M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $1.15M 10-K · filed 2022-03-31 | |
| 2019-09-30 | $1.06M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.06M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $1.02M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $911.00K 10-K · filed 2021-03-31 | $912.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | $879.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $886.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $858.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $858.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $860.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $860.00K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $870.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $872.00K 10-K · filed 2018-03-30 | |
| 2016-09-30 | $919.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $899.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $893.00K 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $862.00K 10-K · filed 2017-03-31 | |
| 2015-09-30 | $883.00K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $951.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $935.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $861.00K 10-K · filed 2016-03-29 | |
| 2014-09-30 | $853.00K 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $924.00K 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $990.00K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $1.08M 10-K · filed 2015-03-19 | |
| 2013-09-30 | $1.07M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $1.07M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $1.08M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $1.03M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $947.00K 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $886.00K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $861.00K 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $863.00K 10-K · filed 2013-03-18 | |
| 2011-09-30 | $725.00K 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $735.00K 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $794.00K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |